SlideShare a Scribd company logo
1 of 4
Download to read offline
1
Jeffrey S. Spigel
jspigel@kslaw.com
+1 202 626 2626
Representative Experience
Civil and Criminal Government Antitrust and Consumer Protection Investigations and Litigation
Energy
 Defending a major global energy company in a DOJ criminal antitrust investigation.
 Successfully defended one of the world’s largest integrated petroleum companies in an industry-wide
civil investigation by the FTC involving the refining, distribution, and sale of light petroleum products in
the United States, as well as possible price gouging in the sale of these products. Also assisted the client
in responding to concurrent congressional investigations. Successfully convinced the FTC of no illegal
conduct by the client, which the FTC reported in its Report of Gasoline Price Manipulation and Post-
Katrina Price Increases.
 Successfully defended one of the world’s largest off-shore supply vessel manufacturer and operator in a
DOJ investigation of an acquisition of competing shipbuilder and operator of repair dry docks. The
transaction closed without DOJ action.
 Successfully defended Varel Energy Services, which is a leading mining and oil & gas drill bit
manufacturer in a DOJ investigation of a transaction with Sandvik AB. The transaction closed without
DOJ action.
 Successfully defended Weatherford International in a DOJ review of the sale of its pipeline and specialty
services business to Baker-Hughes Incorporated. The transaction closed without DOJ action.
 Successfully defended Mirant Corporation in a DOJ antitrust investigation of its merger with RRI
Energy. The transaction closed without DOJ action.
 Represented Torch Offshore Inc. in a DOJ investigation of its sale of certain assets to Cal Dive
International. The divested assets included two shelf pipelay barges, four shelf diving vessels, a
deepwater pipelay vessel, and a portable saturation diving system.
 Successfully defended a gas storage company in an FTC antitrust investigation of its acquisition of a
competitor. The transaction closed without FTC action.
2
 Represented Trigen Energy in a Section 2 Sherman Act lawsuit against Oklahoma Gas & Electric
alleging monopolization of the district cooling market in downtown Oklahoma City. Successful jury
trial with an award of treble damages (Trigen Energy Corporation v. Oklahoma Gas & Electric).
Financial Services
 Defending Countrywide Financial Corporation, which is a Bank of America subsidiary, in an FTC
consumer protection investigation and litigation involving Countrywide’s mortgage loan servicing
practices; negotiated settlement provisions were reflected in subsequent National Servicing Standards
(FTC v. Countrywide Home Loans, Inc.).
 Successfully defended a Fortune 100 insurance client in a DOJ civil investigation of certain industry-
wide practices of consultants. The investigation closed without DOJ action.
 Successfully defended John H. Harland in a DOJ merger investigation of Harland’s acquisition by Clarke
American. The merger resulted in the consolidation of the number of national check printers in the
United States from three to two. The investigation closed without DOJ action.
Healthcare/Life Sciences
 Advising numerous healthcare provider clients in active merger and acquisition discussions with
competitors. As a result of the intense scrutiny by the FTC on healthcare consolidation, these
transactions raise significant and complex antitrust issues.
 Defending a 500-plus physician member network in an FTC price fixing investigation.
 Represented one of the leading global branded pharmaceutical companies in DOJ and FTC antitrust
investigations of a proposed patent settlement with a generic drug company and the use of authorized
generics.
 Successfully defended Capella Healthcare in an FTC merger investigation of its acquisition of five
hospitals from HCA, and the simultaneous sale of one of the hospitals to the St. Francis Medical Center
in Monroe, Louisiana (February 4, 2009 FTC Staff Closing Letter).
 Successfully defended King’s Daughter Hospital in its acquisition by Scott & White Healthcare, which
ultimately received clearance by the FTC under a failing firm defense.
 Successfully defended Piedmont Healthcare, Inc. in an FTC merger investigation of Piedmont’s
acquisition of Newnan Hospital. Convinced the FTC to close the investigation without any action (Feb.
28, 2007 FTC Closing Letter).
 Successfully defended physician clients and their messenger model network in an FTC civil price fixing
and concerted refusal to deal investigation. Convinced the FTC to close the investigation without any
action.
 Defended South Georgia Health Partners in an FTC civil price fixing and concerted refusal to deal
investigation of a super PHO comprised of five hospitals, as well as and over 400 physicians.
Successfully negotiated a settlement to resolve FTC concerns, which enabled the member PHOs to
continue operating (In re South Georgia Health Partners, L.L.C.).
 Represented Hospital Corporation of America in a Sections 1 and 2 Sherman Act (tying) federal antitrust
action against a competing hospital system. The action challenges certain anticompetitive tying practices
3
by Phoebe Putney, which is the dominant medical center in southwest Georgia. (Palmyra Park Medical
Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.).
Manufacturing/Chemical
 Successfully defended a leading manufacturer of containerboard in a DOJ acquisition of a competing
virgin mill. The transaction closed without FTC action.
 Representing Central American Poultry Export Quota, Inc. (“CA-PEQ”), one of the largest U.S. poultry
exporters, in connection with DOJ and Commerce Department reviews of its export trading activities
with certain Central American countries.
 Defended UCAR International (now GrafTech) in a federal grand jury price fixing investigation.
Criminal complaint filed by the DOJ, which was settled successfully for $100 million (United States v.
UCAR International Inc.).
 Successfully defended a number of domestic manufacturers in an FTC investigation into antidumping
settlement agreements between the domestic manufacturers and foreign competitors. The investigation
closed without FTC action.
 Represented Blue Circle Cement in an FTC investigation of its merger with LaFarge S.A. Successfully
negotiated a settlement with the FTC (In re LaFarge S.A.).
Media/Publishing
 Successfully defended a multinational publisher in a DOJ merger investigation of an acquisition of a
competitor.
 Successfully represented Carmike Cinemas in its acquisition of strategic divestiture assets resulting from
DOJ’s action in the Cinemark/Rave Cinemas transaction (United States and State of Texas v. Cinemark
Holdings, Inc., Rave Holdings, LLC, and Alder Wood Partners, L.P.).
 Successfully defended Crawford Communications in a DOJ investigation of its strategic acquisition by
Broadcast Facilities. The investigation closed without DOJ action.
 Successfully defended a leading manufacturer and retailer of fishing boats in an FTC investigation of an
acquisition of a competitor. The transaction closed without FTC action.
 Successfully defended Hanesbrands in an FTC investigation of its acquisition of Maidenform. The
transaction closed without FTC action.
 Successfully defended a Fortune 100 client in a DOJ civil bid-rigging investigation. The investigation
closed without DOJ action.
 Successfully defended The Belk Stores in FTC merger investigations of its acquisitions of the Parisian,
Proffitt’s and McCrae’s department store chains from Saks Fifth Avenue.
 Successfully defended McLane Company in a Section 1 Sherman Act in an action in federal District
Court in Connecticut. The suit alleged federal and state antitrust tying violations arising from the sale of
products to the Plaintiff. McLane’s motion to dismiss with prejudice was granted by the federal District
Court (Loretta N. Bansavich D/B/A/ Lori’s Mobil v. McLane Company, Inc.).
4
Technology
 Successfully defended ChoicePoint in an FTC merger investigation of ChoicePoint’s acquisition by Reed
Elsevier.
 Successfully defended Sprint in a DOJ investigation of its $35 billion merger with Nextel.
 Successfully defended Sprint in a DOJ investigation of its multi-billion dollar Global One joint venture
with France Telecom and Deutsche Telekom. Successfully negotiated a settlement with DOJ (United
States v. Sprint Corporation and Joint Venture Co.).
 Successfully defended a satellite broadcasting company in a DOJ investigation of a merger with a
competitor. The investigation closed without DOJ action.
Counseling
 Advises clients on antitrust issues arising from their everyday business practices, including compliance
and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, Robinson-
Patman price discrimination, refusals to deal, and tying and predatory bundling issues.
 Obtained HSR clearances for hundreds of transactions.

More Related Content

Similar to Spigel_5251_bio

A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...
A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...
A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...Lawrence Kass
 
NYLJ_Drug Patents in the Spotlight
NYLJ_Drug Patents in the SpotlightNYLJ_Drug Patents in the Spotlight
NYLJ_Drug Patents in the SpotlightLawrence Kass
 
6. rems. the next pharmaceutical enforcement priority
6.  rems. the next pharmaceutical enforcement priority6.  rems. the next pharmaceutical enforcement priority
6. rems. the next pharmaceutical enforcement priorityMatias González Muñoz
 
Case Analysis · Post a brief case analysis of a listed problem f.docx
Case Analysis · Post a brief case analysis of a listed problem f.docxCase Analysis · Post a brief case analysis of a listed problem f.docx
Case Analysis · Post a brief case analysis of a listed problem f.docxwendolynhalbert
 
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...gruesomeknoll613
 
resume polished 2-1-17
resume polished 2-1-17resume polished 2-1-17
resume polished 2-1-17Steven Hamrick
 
Mensing Reglan/Generics opinion
Mensing Reglan/Generics opinionMensing Reglan/Generics opinion
Mensing Reglan/Generics opinionmzamoralaw
 
KJO Representative Matters
KJO Representative MattersKJO Representative Matters
KJO Representative MattersKevin O'Shea
 
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...morsemh
 
False Claims Act Focus ~ April 2013
False Claims Act Focus ~ April 2013False Claims Act Focus ~ April 2013
False Claims Act Focus ~ April 2013Patton Boggs LLP
 
Select Antitrust Issues for Technology Companies
Select Antitrust Issues for Technology CompaniesSelect Antitrust Issues for Technology Companies
Select Antitrust Issues for Technology CompaniesCTChris
 
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...Heather Cooper
 
DMD reed smith bio september 2016
DMD reed smith bio september 2016DMD reed smith bio september 2016
DMD reed smith bio september 2016Donna Doblick
 
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...steinuyvodepxvk
 
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerNexsen Pruet
 
ELI Conference on BLM Fracking Rule
ELI Conference on BLM Fracking RuleELI Conference on BLM Fracking Rule
ELI Conference on BLM Fracking RulePaul Smyth
 

Similar to Spigel_5251_bio (20)

A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...
A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...
A Computerized Business Method Is Patentable Subject Matter, N.Y.L.J., August...
 
NYLJ_Drug Patents in the Spotlight
NYLJ_Drug Patents in the SpotlightNYLJ_Drug Patents in the Spotlight
NYLJ_Drug Patents in the Spotlight
 
6. rems. the next pharmaceutical enforcement priority
6.  rems. the next pharmaceutical enforcement priority6.  rems. the next pharmaceutical enforcement priority
6. rems. the next pharmaceutical enforcement priority
 
Case Analysis · Post a brief case analysis of a listed problem f.docx
Case Analysis · Post a brief case analysis of a listed problem f.docxCase Analysis · Post a brief case analysis of a listed problem f.docx
Case Analysis · Post a brief case analysis of a listed problem f.docx
 
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
 
resume polished 2-1-17
resume polished 2-1-17resume polished 2-1-17
resume polished 2-1-17
 
Mensing Reglan/Generics opinion
Mensing Reglan/Generics opinionMensing Reglan/Generics opinion
Mensing Reglan/Generics opinion
 
KJO Representative Matters
KJO Representative MattersKJO Representative Matters
KJO Representative Matters
 
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...
Drinker Biddle ABA Antitrust Section Corporate Counseling September October U...
 
PWW - CV
PWW - CVPWW - CV
PWW - CV
 
False Claims Act Focus ~ April 2013
False Claims Act Focus ~ April 2013False Claims Act Focus ~ April 2013
False Claims Act Focus ~ April 2013
 
Select Antitrust Issues for Technology Companies
Select Antitrust Issues for Technology CompaniesSelect Antitrust Issues for Technology Companies
Select Antitrust Issues for Technology Companies
 
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...
Schering Ploughs $41 Billion Acquisition Of Merck Clears Antitrust Hurdles Wi...
 
Law360_DFA_073115
Law360_DFA_073115Law360_DFA_073115
Law360_DFA_073115
 
DMD reed smith bio september 2016
DMD reed smith bio september 2016DMD reed smith bio september 2016
DMD reed smith bio september 2016
 
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One ...
 
MedMal news
MedMal newsMedMal news
MedMal news
 
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
 
ELI Conference on BLM Fracking Rule
ELI Conference on BLM Fracking RuleELI Conference on BLM Fracking Rule
ELI Conference on BLM Fracking Rule
 
Cpi Article Cooper
Cpi Article CooperCpi Article Cooper
Cpi Article Cooper
 

Spigel_5251_bio

  • 1. 1 Jeffrey S. Spigel jspigel@kslaw.com +1 202 626 2626 Representative Experience Civil and Criminal Government Antitrust and Consumer Protection Investigations and Litigation Energy  Defending a major global energy company in a DOJ criminal antitrust investigation.  Successfully defended one of the world’s largest integrated petroleum companies in an industry-wide civil investigation by the FTC involving the refining, distribution, and sale of light petroleum products in the United States, as well as possible price gouging in the sale of these products. Also assisted the client in responding to concurrent congressional investigations. Successfully convinced the FTC of no illegal conduct by the client, which the FTC reported in its Report of Gasoline Price Manipulation and Post- Katrina Price Increases.  Successfully defended one of the world’s largest off-shore supply vessel manufacturer and operator in a DOJ investigation of an acquisition of competing shipbuilder and operator of repair dry docks. The transaction closed without DOJ action.  Successfully defended Varel Energy Services, which is a leading mining and oil & gas drill bit manufacturer in a DOJ investigation of a transaction with Sandvik AB. The transaction closed without DOJ action.  Successfully defended Weatherford International in a DOJ review of the sale of its pipeline and specialty services business to Baker-Hughes Incorporated. The transaction closed without DOJ action.  Successfully defended Mirant Corporation in a DOJ antitrust investigation of its merger with RRI Energy. The transaction closed without DOJ action.  Represented Torch Offshore Inc. in a DOJ investigation of its sale of certain assets to Cal Dive International. The divested assets included two shelf pipelay barges, four shelf diving vessels, a deepwater pipelay vessel, and a portable saturation diving system.  Successfully defended a gas storage company in an FTC antitrust investigation of its acquisition of a competitor. The transaction closed without FTC action.
  • 2. 2  Represented Trigen Energy in a Section 2 Sherman Act lawsuit against Oklahoma Gas & Electric alleging monopolization of the district cooling market in downtown Oklahoma City. Successful jury trial with an award of treble damages (Trigen Energy Corporation v. Oklahoma Gas & Electric). Financial Services  Defending Countrywide Financial Corporation, which is a Bank of America subsidiary, in an FTC consumer protection investigation and litigation involving Countrywide’s mortgage loan servicing practices; negotiated settlement provisions were reflected in subsequent National Servicing Standards (FTC v. Countrywide Home Loans, Inc.).  Successfully defended a Fortune 100 insurance client in a DOJ civil investigation of certain industry- wide practices of consultants. The investigation closed without DOJ action.  Successfully defended John H. Harland in a DOJ merger investigation of Harland’s acquisition by Clarke American. The merger resulted in the consolidation of the number of national check printers in the United States from three to two. The investigation closed without DOJ action. Healthcare/Life Sciences  Advising numerous healthcare provider clients in active merger and acquisition discussions with competitors. As a result of the intense scrutiny by the FTC on healthcare consolidation, these transactions raise significant and complex antitrust issues.  Defending a 500-plus physician member network in an FTC price fixing investigation.  Represented one of the leading global branded pharmaceutical companies in DOJ and FTC antitrust investigations of a proposed patent settlement with a generic drug company and the use of authorized generics.  Successfully defended Capella Healthcare in an FTC merger investigation of its acquisition of five hospitals from HCA, and the simultaneous sale of one of the hospitals to the St. Francis Medical Center in Monroe, Louisiana (February 4, 2009 FTC Staff Closing Letter).  Successfully defended King’s Daughter Hospital in its acquisition by Scott & White Healthcare, which ultimately received clearance by the FTC under a failing firm defense.  Successfully defended Piedmont Healthcare, Inc. in an FTC merger investigation of Piedmont’s acquisition of Newnan Hospital. Convinced the FTC to close the investigation without any action (Feb. 28, 2007 FTC Closing Letter).  Successfully defended physician clients and their messenger model network in an FTC civil price fixing and concerted refusal to deal investigation. Convinced the FTC to close the investigation without any action.  Defended South Georgia Health Partners in an FTC civil price fixing and concerted refusal to deal investigation of a super PHO comprised of five hospitals, as well as and over 400 physicians. Successfully negotiated a settlement to resolve FTC concerns, which enabled the member PHOs to continue operating (In re South Georgia Health Partners, L.L.C.).  Represented Hospital Corporation of America in a Sections 1 and 2 Sherman Act (tying) federal antitrust action against a competing hospital system. The action challenges certain anticompetitive tying practices
  • 3. 3 by Phoebe Putney, which is the dominant medical center in southwest Georgia. (Palmyra Park Medical Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.). Manufacturing/Chemical  Successfully defended a leading manufacturer of containerboard in a DOJ acquisition of a competing virgin mill. The transaction closed without FTC action.  Representing Central American Poultry Export Quota, Inc. (“CA-PEQ”), one of the largest U.S. poultry exporters, in connection with DOJ and Commerce Department reviews of its export trading activities with certain Central American countries.  Defended UCAR International (now GrafTech) in a federal grand jury price fixing investigation. Criminal complaint filed by the DOJ, which was settled successfully for $100 million (United States v. UCAR International Inc.).  Successfully defended a number of domestic manufacturers in an FTC investigation into antidumping settlement agreements between the domestic manufacturers and foreign competitors. The investigation closed without FTC action.  Represented Blue Circle Cement in an FTC investigation of its merger with LaFarge S.A. Successfully negotiated a settlement with the FTC (In re LaFarge S.A.). Media/Publishing  Successfully defended a multinational publisher in a DOJ merger investigation of an acquisition of a competitor.  Successfully represented Carmike Cinemas in its acquisition of strategic divestiture assets resulting from DOJ’s action in the Cinemark/Rave Cinemas transaction (United States and State of Texas v. Cinemark Holdings, Inc., Rave Holdings, LLC, and Alder Wood Partners, L.P.).  Successfully defended Crawford Communications in a DOJ investigation of its strategic acquisition by Broadcast Facilities. The investigation closed without DOJ action.  Successfully defended a leading manufacturer and retailer of fishing boats in an FTC investigation of an acquisition of a competitor. The transaction closed without FTC action.  Successfully defended Hanesbrands in an FTC investigation of its acquisition of Maidenform. The transaction closed without FTC action.  Successfully defended a Fortune 100 client in a DOJ civil bid-rigging investigation. The investigation closed without DOJ action.  Successfully defended The Belk Stores in FTC merger investigations of its acquisitions of the Parisian, Proffitt’s and McCrae’s department store chains from Saks Fifth Avenue.  Successfully defended McLane Company in a Section 1 Sherman Act in an action in federal District Court in Connecticut. The suit alleged federal and state antitrust tying violations arising from the sale of products to the Plaintiff. McLane’s motion to dismiss with prejudice was granted by the federal District Court (Loretta N. Bansavich D/B/A/ Lori’s Mobil v. McLane Company, Inc.).
  • 4. 4 Technology  Successfully defended ChoicePoint in an FTC merger investigation of ChoicePoint’s acquisition by Reed Elsevier.  Successfully defended Sprint in a DOJ investigation of its $35 billion merger with Nextel.  Successfully defended Sprint in a DOJ investigation of its multi-billion dollar Global One joint venture with France Telecom and Deutsche Telekom. Successfully negotiated a settlement with DOJ (United States v. Sprint Corporation and Joint Venture Co.).  Successfully defended a satellite broadcasting company in a DOJ investigation of a merger with a competitor. The investigation closed without DOJ action. Counseling  Advises clients on antitrust issues arising from their everyday business practices, including compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, Robinson- Patman price discrimination, refusals to deal, and tying and predatory bundling issues.  Obtained HSR clearances for hundreds of transactions.